Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03909334
Title Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Xiuning Le
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown University Washington District of Columbia 20057 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
Indiana Univesity Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Summit Medical Group, PA Berkeley Heights New Jersey 07922 United States Details
New York University Cancer Center New York New York 10016 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Virginia Health System Charlottesville Virginia 22908 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field